enspryng-hcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /content/dam/gene/enspryng-hcp/resources/ SITEMAP: | ||
Meta Tags
| Title | ENSPRYNG® (satralizumab) for NMOSD Treatment | Efficacy, Safety, & Prescribing |
| Description | REDUCE RELAPSE RISK WITH ENSPRYNG® (satralizumab) is an interleukin-6 (IL-6) receptor antagonist indicated as monotherapy or with immunosuppressive therapy for the treatment of neuromyelitis optica spectrum disorder (NMOSD). See full safety for more |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.18.9.131 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
enspryng-hcp.com Valuation
|
US$3,283,899
Last updated: 2023-05-08 23:44:06
enspryng-hcp.com has Semrush global rank of 3,223,091. enspryng-hcp.com has an estimated worth of US$ 3,283,899, based on its estimated Ads revenue. enspryng-hcp.com receives approximately 378,912 unique visitors each day. Its web server is located in United States, with IP address 104.18.9.131. According to SiteAdvisor, enspryng-hcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,283,899 |
| Daily Ads Revenue | US$3,032 |
| Monthly Ads Revenue | US$90,939 |
| Yearly Ads Revenue | US$1,091,265 |
| Daily Unique Visitors | 25,261 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| enspryng-hcp.com. | A | 299 | IP: 104.18.9.131 |
| enspryng-hcp.com. | A | 299 | IP: 104.18.8.131 |
| enspryng-hcp.com. | AAAA | 299 | IPV6: 2606:4700::6812:983 |
| enspryng-hcp.com. | AAAA | 299 | IPV6: 2606:4700::6812:883 |
| enspryng-hcp.com. | NS | 86400 | NS Record: lara.ns.cloudflare.com. |
| enspryng-hcp.com. | NS | 86400 | NS Record: alan.ns.cloudflare.com. |
| enspryng-hcp.com. | TXT | 300 | TXT Record: j2wvb41cjnswgz950h7w8fhqgvkh3680 |
| enspryng-hcp.com. | TXT | 300 | TXT Record: qw4kh2nfpz91hmz13blhcvdr15qh9gv4 |
HtmlToTextCheckTime:2023-05-08 23:44:06
| For Patients & Caregivers Contact a Rep Contact a Rep Instructions for Use Instructions for Use Medication Guide Medication Guide Prescribing Information Prescribing Information Safety Safety MENU Home About ENSPRYNG How ENSPRYNG Is Thought to Work Efficacy Trial Information Clinical Results Side Effects Side Effects & Trial Safety Important Safety Information Dosing & Administration Before Treatment Dosing Schedule Safety Monitoring Patient & Practice Resources Patient Printables & Helpful Links Helpful Resources for Your Practice Practice Forms & Documents Financial Support Financial Assistance Options Eligibility & Enrollment Financial Support FAQs Patient Navigators Contact a Rep Instructions for Use Medication Guide Prescribing Information Safety For Patients & Caregivers REDUCE RELAPSE RISK WITH ENSPRYNG For neuromyelitis optica spectrum disorder (NMOSD) in adults who are anti-aquaporin-4 (AQP4) antibody positive 1 Learn About ENSPRYNG REDUCE RELAPSE RISK WITH ENSPRYNG For |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sat, 30 Oct 2021 21:56:43 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Sat, 30 Oct 2021 22:56:43 GMT Location: https://enspryng-hcp.com/ Set-Cookie: __cfruid=9826b0822777b6597c8768727caa8d753572db50-1635631003; path=/; domain=.enspryng-hcp.com; HttpOnly Server: cloudflare CF-RAY: 6a67e52d0a1e296e-ORD HTTP/2 301 date: Sat, 30 Oct 2021 21:56:43 GMT content-type: text/html; charset=iso-8859-1 location: https://www.enspryng-hcp.com/ cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=9826b0822777b6597c8768727caa8d753572db50-1635631003; path=/; domain=.enspryng-hcp.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a67e52d5fa2e1d2-ORD HTTP/2 200 date: Sat, 30 Oct 2021 21:56:44 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=5efbcfe03353f90d0645e61bd1453f59ae343347-1635631004; path=/; domain=.enspryng-hcp.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a67e52f5a1a2d76-ORD |
enspryng-hcp.com Whois Information
Domain Name: ENSPRYNG-HCP.COM Registry Domain ID: 2437304919_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2021-07-20T09:48:03Z Creation Date: 2019-09-25T22:32:16Z Registry Expiry Date: 2021-09-25T22:32:16Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ALAN.NS.CLOUDFLARE.COM Name Server: LARA.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T08:10:54Z <<< |